In short: Most early-stage biotechs bring in their first permanent Quality or Regulatory hire later than they should, often only when an audit, a funding milestone or a submission is close. Hiring Quality and Regulatory people earlier costs less over time, makes inspections less stressful and builds the credibility that investors and partners look for.
When do biotechs make their first Quality or Regulatory hire?
In my experience, most biotechs do not start with a permanent hire at all. They start with contractors, interim support or consultants brought in as needed, to get the basics in place. The first permanent hire usually follows later, once the company is approaching a funding milestone, an audit or its first regulatory submission.
I will admit my bias, but I think that hire should come much earlier. A quality system built properly from the start saves a great deal of pain later on: rewriting SOPs that were drafted in a hurry, or moving from a paper-based system to an electronic quality management system (eQMS) while everything else is also changing. On the regulatory side, an early hire means the dossier is built steadily over time, rather than in a rush just before a submission to a regulator such as the FDA [1] or the MHRA [2].
What goes wrong when the hire comes too late?
There are three problems I see most often.
1. Spending more than you need to. Consultants on hourly or daily rates are valuable, and there is nothing wrong with using them. But if a company relies on them for too long, the cost builds up. For a pre-seed or early-stage company, every pound or dollar of investment matters, and that money could have gone further.
2. Rushing inspection readiness. When the first Quality person arrives shortly before an audit or inspection, they have very little time. SOPs need writing, gaps need closing, a mock audit needs running. Less preparation time means more room for gaps that an investigator can find. In the US, inspection findings are recorded on FDA Form 483 [3], and significant violations can lead to a warning letter [4].
3. Losing trust. Partners, investors and customers want to see that a credible Quality and Regulatory person is accountable for the work. A consultant can do excellent work, but they carry little long-term responsibility for the product. A permanent team member, perhaps with shares in the business, is invested in seeing the product approved and on the market. Without that person, a company can find it harder to win and keep the partners it needs.
Why do founders and boards delay it?
Quite often, Quality and Regulatory are seen as a cost centre. They do not generate revenue. What they do is prevent problems, fines and delays further down the line, and that value is harder to see on a spreadsheet. In my experience, when larger companies make redundancies, Quality and Regulatory roles are often among the first to be reviewed, on the basis that someone could cover the work remotely or on a consulting basis.
Founders are understandably focused on getting their product to market: trials, development, fundraising, sales and marketing. A Quality or Regulatory lead is sometimes the person who says “no”, or “not like that”, in order to stay compliant. That can feel like friction. In reality, it is exactly the friction that keeps a company out of trouble later.
What should a founder look for in that first hire?
Nobody knows everything, and the first hire does not need to. What matters is that they know how to find the right information quickly. In Regulatory Affairs especially, the rules differ by product type and by country. A strong first hire knows where to look, and has a network to ask.
In Quality, look for someone who knows compliance inside out and can quickly turn the company’s goals into the right quality system, processes and SOPs. The best candidates often arrive with proven templates and tools, so they can start without delay.
Above all, look for a business mindset. The first Quality or Regulatory person is not someone who simply comes in, does the work and goes home. They need to understand how the business runs, shape regulatory and compliance strategy around its goals, and keep the high-level picture in view.
One combined Quality and Regulatory person, or two?
It depends on the size and the nature of the business. In medical devices, medtech and diagnostics, a combined Quality and Regulatory (QARA) role is common in small and medium-sized companies, and the two are usually split as the company grows. In pharma and biotech, they are more often separate from the start.
Candidates are split on this too. Some are comfortable covering both; others feel strongly that the two need different people. Nobody is right or wrong. The answer depends on the workload, the product and the person.
What slows the hire down once a company starts looking?
The most common delay is the hope that someone better might come along. It is like shopping for shoes: you find a pair you like in the first shop, then walk around town for another hour before going back, hoping they still have your size. If the first suitable candidate is right for the role, hire them. Moving decisively also tells the candidate you value their experience, rather than keeping them waiting while you look around.
The second problem is the interview process itself. Tasks and presentations can be a fair part of a Quality or Regulatory interview. But sometimes an interview turns into a free consulting session, with the candidate asked how to get an approval or what a notified body audit will cost. That leaves a bad taste. Candidates become guarded, and the process slows down. Keep tasks short, focused and respectful of the candidate’s time.
The one thing to take away
Hiring Quality and Regulatory is just as important as building a sales or marketing team, if not more so. They may not drive revenue directly, but when something goes wrong, they are the people you rely on. They are the firefighters of the industry. You do not always need them, but when you do, you really need them. If you want to avoid getting burnt, have a firefighter on board before the fire starts.
FAQ
When should a biotech hire its first Quality person?
Earlier than most do: ideally before the quality system has to be rebuilt for an audit, a funding round or a first submission.
Is it better to use consultants or a permanent hire?
Consultants are useful early on, but relying on them for too long tends to cost more and leaves no one permanently accountable for compliance.
Should Quality and Regulatory be one role or two?
In smaller device and diagnostics companies, often one. In pharma and biotech, more often two. It depends on workload and the product.
Author Bio













